AMEAmetek
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $2.21Beat
- vs $2.12 expected on Nov 3
- Stock move on it
- −1.99%
- two sessions around the report
- Typical move
- ±2.4%
- average over 2 reports
- Price
- $241.04
- +0.56% today · $53.9B cap
Past and upcoming reports
2
| Nov 3, 2026 | Sep 30, 2026 | Time not given | $2.12 | Beat$2.21 | −1.99%2d |
| Jul 30, 2026 | Jun 30, 2026 | Time not given | $1.99 | not recorded | +2.75%2d |
After the report
Jul 30, 2026 report
This covers the Jul 30, 2026 report. The Nov 3, 2026 numbers are in the table above.
AME edges up 0.66% post-earnings. actuals pending, focus shifts to Aug 4 guidance
Ametek (AME) reported Q2 earnings on July 30 with consensus EPS estimate of $1.99. Actual results are not yet confirmed, but the stock rose 0.66% on the following day, indicating a neutral-to-positive reception. No significant post-earnings news or analyst calls have emerged. The company's fundamentals remain solid with strong quality and valuation metrics, though growth is mixed. The next catalyst is the upcoming earnings call on August 4, where Q3 guidance is expected.
Reported against expected
Consensus EPS estimate was $1.99. actual results not yet confirmed. Stock rose 0.66% on the day after the print, suggesting a modestly positive market reaction.
Guidance
No explicit guidance data available in the payload. Forward guidance is expected to be provided during the Aug 4 earnings call.
How the stock reacted
The stock closed at $241.60 on July 31, up 0.66% from the previous close of $240.01. The day's range was $240.61-$244.97. Volume was 725,945, below the 90-day average for some periods.
What changed
Stock rose 0.66% after earnings, in line with muted expectations.
What the price now assumes
Market pricing AME for steady growth, supported by 8.4% EPS growth TTM and 36.5 P/E.
What it means for the business
Maintain bias. watch for Q3 guidance and next catalyst on Aug 4.
The next one to three months, as we saw it then
Better case30%
Q3 guidance exceeds consensus, accelerating organic growth and margin expansion drive re-rating toward analyst target of $257.
Base case50%
Q3 guidance in line with consensus, modest growth continues, stock trades within $235-$250 range as fundamentals hold steady.
Worse case20%
Q3 guidance disappoints, margin pressure from cost inflation or currency headwinds, P/E multiple contracts toward 32x support near $230.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.